Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,811 | -22,043 | -25,295 | -200,403 | -166,637 |
| Depreciation Amortization | 1,708 | 1,155 | 577 | 2,379 | 1,853 |
| Accounts receivable | 1,139 | 1,290 | 1,026 | -2,463 | -1,885 |
| Accounts payable and accrued liabilities | -24,573 | -10,569 | -21,692 | 14,801 | 5,673 |
| Other Working Capital | -22,346 | -8,034 | -19,237 | 14,238 | 2,470 |
| Other Operating Activity | 28,265 | 11,416 | 20,843 | -7,332 | 1,237 |
| Operating Cash Flow | $-50,618 | $-26,785 | $-43,778 | $-178,780 | $-157,289 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 108,190 | 56,065 | 40,582 | -14,347 | -68,521 |
| PPE Investments | N/A | N/A | N/A | -1,031 | -557 |
| Investing Cash Flow | $108,190 | $56,065 | $40,582 | $-15,378 | $-69,078 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -45,000 | -45,000 | N/A | N/A | N/A |
| Common Stock Issued | -572 | N/A | N/A | 64 | -1,641 |
| Common Stock Repurchased | N/A | -572 | -572 | -1,730 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 240,015 | 240,094 |
| Financing Cash Flow | $-45,572 | $-45,572 | $-572 | $238,349 | $238,453 |
| Beginning Cash Position | 66,656 | 66,656 | 66,656 | 22,465 | 22,465 |
| End Cash Position | 78,656 | 50,364 | 62,888 | 66,656 | 34,551 |
| Net Cash Flow | $12,000 | $-16,292 | $-3,768 | $44,191 | $12,086 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,618 | -26,785 | -43,778 | -178,780 | -157,289 |
| Capital Expenditure | N/A | N/A | N/A | -1,031 | -557 |
| Free Cash Flow | -50,618 | -26,785 | -43,778 | -179,811 | -157,846 |